Laminated & Aluminium Squeeze Tube — Regulatory & Compliance Guide

Why Regulatory Rejections Happen After Production, Not Before #

A brand we work with regularly — a mid-size personal care company supplying both EU retail chains and US specialty stores — ran into a customs hold in Hamburg on a shipment of 80,000 laminated tubes. The issue wasn’t the tube substrate. It was an offset overprint varnish applied to the exterior that contained a photoinitiator not cleared under EU Regulation No 10/2011. The varnish was food-contact-adjacent by proximity, the laminate had a foil layer, and the customs inspector flagged it under the REACH-adjacent cosmetic packaging assessment protocol.

The hold cost them 11 days and a full third-party migration test before clearance. No reformulation was needed — just documentation they didn’t have on file. The tube itself was compliant. The paperwork trail wasn’t.

This is the pattern we see repeatedly in our compliance intake process (what we track internally as our Reg-01 documentation gate): the physical tube meets the underlying material standards, but the regulatory documentation package — SDS, migration test reports, substance declarations, and regional conformity statements — is either missing, expired, or formatted for the wrong market. Getting the tube right and getting the paperwork right are two separate workflows, and skipping the second one after completing the first is the most expensive mistake in squeeze tube export.

The Parameters That Actually Drive Regulatory Classification #

Squeeze tube compliance sits at the intersection of three regulatory domains: food/cosmetic contact safety, restricted substance frameworks, and country-of-origin labeling rules. The specific tube construction determines which rules apply and how strictly.

Wall thickness and barrier layer identity are the starting point. ABL (aluminium barrier laminate) tubes carry a metallic foil layer, typically 9–12 µm thick, which classifies the entire construction as a multi-material article under EU Regulation 10/2011 and triggers Article 12 framework provisions for non-plastic layers. PBL (plastic barrier laminate) tubes without metallic content fall more cleanly under the plastics-only framework, but their ethylene vinyl alcohol (EVOH) barrier layers — usually 15–25 µm — must still be assessed for monomer migration under ASTM F1927 oxygen transmission methodology if the end product has any food-adjacent claim.

Ink and lacquer systems are the most commonly overlooked compliance variable. Our standard practice is to require full substance declarations from ink suppliers to 0.1% (w/w) — the REACH threshold under EU SVHC Regulation (EC) No 1907/2006 — for any colorant or coating applied within 2mm of the laminate shoulder seam. Exterior flexo inks on tubes with no barrier separation to the fill product need migration clearance under EU Regulation No 2023/2006 (Good Manufacturing Practice for food contact materials), even when the ink is technically “exterior.”

Shoulder resin type matters more than most specification sheets acknowledge. The shoulder is almost always injection-molded HDPE or PP. Both are FDA-listed under 21 CFR §177.1520 for food contact olefins, but the colorant system within the shoulder resin must be separately assessed — carbon black grades, titanium dioxide particle size, and cadmium-based pigments each carry distinct restrictions under EN 71-3:2019+A1:2021 for toys (relevant when tubes are used in children’s toothpaste or craft products) and under REACH Annex XVII for general consumer goods.

Fill product chemistry closes the loop. A 70% ethanol hand sanitizer will leach differently from a LDPE/EVOH/LDPE laminate than a water-based moisturizer does. Our Reg-01 gate requires the fill product’s chemical classification (aqueous, fatty, alcoholic, or acidic per EU simulant categories) before we confirm laminate suitability — because the same tube construction that passes migration testing with simulant A (10% ethanol) may exceed the 10 mg/dm² overall migration limit under simulant D2 (vegetable oil) for high-fat topical formulations.

The most commonly overlooked parameter in our experience is the GMP documentation chain for converting operations. A tube may use fully compliant substrates from certified suppliers, but if the converting facility (lamination, flexo printing, shoulder injection, capping) lacks its own GMP audit or ISO 22000 scope covering packaging materials, the EU market’s traceability requirement under Article 17 of EU 10/2011 is technically unmet. We maintain a converting facility GMP record updated annually — covering press cleaning protocols, ink lot traceability, and contamination prevention procedures — specifically because customer audits increasingly request it for EU and UK market shipments.

If Your Product Crosses Multiple Markets, the Documentation Stack Changes #

If you’re shipping the same tube SKU to the EU and the US simultaneously, the regulatory documentation you need is not the union of two lists — it’s two separate packages with overlapping but non-identical content.

For US market only, the practical requirement is a supplier letter of guarantee citing the applicable 21 CFR sections for each material layer, plus an extractables/leachables study if the fill product is OTC drug-classified (e.g., SPF sunscreen, fluoride toothpaste). FDA doesn’t mandate a Declaration of Compliance document, but retailers like Target and Walmart have their own supplier compliance programs (RSP/TSP) that functionally require equivalent documentation.

For EU market only, you need a formal DoC per Article 16 of EU 10/2011 referencing the regulation, the specific food contact use, and the identity of all substances used above the detection threshold. For cosmetic products, additionally the EU Cosmetics Regulation (EC) 1223/2009 requires a Product Safety Report (PSR) that addresses packaging material safety as part of the product dossier. Post-Brexit, the UK requires a parallel UKCA-aligned DoC for Great Britain — Northern Ireland still follows EU rules under the Windsor Framework.

If you’re also selling into China, GB 9685-2016 permitted additive lists don’t always overlap with EU 10/2011 positive lists. A plasticizer approved in China may not be EU-listed, and vice versa. For a brand running truly tri-market SKUs, we typically recommend specifying the most restrictive overlap across all three frameworks from the substrate specification stage — which in practice usually means building to EU 10/2011 as the baseline, then verifying FDA and GB 9685 compliance as secondary confirmations. This approach adds roughly 15–20 days to initial qualification but eliminates the risk of post-production reformulation.

One scenario where this strategy doesn’t work cleanly: tubes designed for the Chinese domestic market where GB 9685-2016 permits specific additives not on any EU positive list. In those cases, the formulation genuinely diverges by market, and we maintain separate raw material specifications and DoC documents for each.

Our standard lead time for a full tri-market compliance documentation package — from confirmed substrate specification to completed DoC set — is 18–25 working days, assuming no migration testing is needed. If ASTM F1308 extractables testing or EU simulant migration testing is required, add 20–30 working days for third-party lab turnaround.

Specification Notes for Brand Partners #

When you brief us on a laminated or aluminium squeeze tube project with export requirements, the information that directly determines compliance scope is: fill product classification (aqueous/fatty/alcoholic/acidic), target markets by country, and whether the product carries any drug or OTC claim in any of those markets. Without the fill chemistry, we cannot confirm laminate suitability — and without the market list, we can’t scope the documentation package.

The gap that generates the most sample iterations in our experience is incomplete colorant data for the shoulder resin. Brands often specify “white shoulder, HDPE” without providing the masterbatch supplier or the colorant formulation. If that white masterbatch contains a titanium dioxide grade not covered under EU 10/2011 positive list or uses an optical brightener outside REACH compliance, we catch it at our Reg-01 gate and have to request a reformulated masterbatch — which can add 10–15 working days to sampling.

Our standard sampling timeline for a compliant laminated tube with full documentation is 20–28 working days from confirmed specification. Projects requiring new laminate structure qualification or third-party migration testing extend to 45–55 working days. Providing a complete initial brief — substrate target, fill product SDS, market list, decoration intent — at project kickoff is the single most effective way to hold that 20–28 day window.

What documentation do I actually need to import squeeze tubes into the EU?

At minimum: a Declaration of Compliance per Article 16 of EU 10/2011 covering all plastic and multi-material layers in the tube construction, a REACH substance declaration confirming no SVHCs above 0.1% (w/w), and ink/lacquer supplier declarations for any coating applied to the tube. If your fill product is a regulated cosmetic, you’ll also need the packaging material safety section within your EU Cosmetics Product Safety Report. A DoC without supporting substance declarations behind it won’t satisfy a customs query or a retailer audit.

Does FDA require a Declaration of Compliance for squeeze tube packaging?

FDA doesn’t use the DoC format. What FDA requires is that materials comply with the applicable 21 CFR sections — and that compliance is demonstrated through supplier guarantees, GMP records, and, for drug-adjacent products, extractables/leachables data. The practical risk is that US retailer compliance programs (Target, Walmart, Amazon) layer their own documentation requirements on top of FDA’s framework, so “FDA-compliant” isn’t sufficient for retail channel qualification without also meeting those retailer-specific supplier standards.

Our tube passes EU 10/2011 for food contact — does that automatically mean it’s compliant for cosmetic contact in the EU?

No, and this is where the regulatory framework gets genuinely complicated. EU 10/2011 covers food contact plastics. Cosmetic packaging in the EU is assessed under EU Cosmetics Regulation 1223/2009, which requires a safety evaluation of the packaging as part of the Product Safety Report — but doesn’t have its own equivalent positive list for packaging materials the way EU 10/2011 does. So food contact compliance is a strong technical baseline, but it doesn’t substitute for the cosmetics safety assessment. For high-migration-risk applications (oil-based serums, retinol creams, vitamin C formulations in acidic bases), we recommend running the food contact migration test under simulant D1 (50% ethanol) as a conservative proxy for fatty cosmetic formulations, even though it isn’t formally required.

---

Planning a packaging project? Contact our team to request a complimentary specification review and sample quote.